IBP director awarded 855 restricted shares
SCHOTTENSTEIN ROBERT H reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SCHOTTENSTEIN ROBERT H reported acquisition or exercise transactions in this Form 4 filing.
Installed Building Products, Inc. reported that director Robert H. Schottenstein received a grant of 855 shares of restricted common stock at no cost. Following this award, he holds 4,132 common shares directly. The restricted stock will vest after one year, immediately before the first stockholder meeting after the grant date, or upon his death, provided he continues serving on the board until vesting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, $0.01 par value per share | 855 | $0.00 | $0.00 |
Footnotes (1)
- F1. The restricted stock shall vest on the earlier to occur of (i) the one year anniversary of the grant date, (ii) immediately prior to the first annual meeting of the Company's stockholders occurring after the grant date or (iii) the director's death, subject in the cases of (i) and (ii) to such director's continued service as a member of the board of directors from the grant date through the vesting date. The date of grant of the restricted stock was May 19, 2026.
Key Figures
Key Terms
restricted stock financial
grant date financial
vest financial
board of directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IBP director Robert H. Schottenstein report?
When was the restricted stock granted to the IBP director?
AI-generated analysis. How Rhea-AI works. Not financial advice.